AI assistant
Sending…
X4 Pharmaceuticals, Inc — Director's Dealing 2020
Dec 14, 2020
34355_dirs_2020-12-14_656bb330-4ef0-43b0-b651-aecd382d67bc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: X4 Pharmaceuticals, Inc (XFOR)
CIK: 0001501697
Period of Report: 2020-12-14
Reporting Person: Cadavid Diego (Chief Medical Officer)
More from X4 Pharmaceuticals, Inc
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Mar 20
Remuneration Information
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Annual Report
2026
Mar 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17